 |
|
For more information contact Biomoda at
505-821-0875 or Fax:866-519-6156
|
| March
17, 2010 |
Biomoda Announces up to $2.0 Million
Private Placement
Albuquerque,
NM (March 17, 2010) - Cancer diagnostics company
Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com)
today announced that it has entered into agreements with
a syndicate of institutional investors for up to $2.0
million...
|
| |
. . . read the release |
| March
10, 2010 |
Biomoda Awarded Patent Securing Assay
Formulation and Use
ALBUQUERQUE,
N.M.--(BUSINESS WIRE)--Cancer diagnostics company
Biomoda, Inc. (OTC BB: BMOD
- News)
(www.biomoda.com)
and Obio, Inc., a corporation formed to pursue public
and private funding for cancer research in Ohio, are
working together to expand Biomoda’s lung cancer
screening program...
|
| |
. . . read the release |
| March
3, 2010 |
Biomoda and Amigenics Announce
Collaboration
ALBUQUERQUE,
N.M.--(BUSINESS WIRE)--Biomoda, Inc. and Advanced
Medical Imaging and Genetics (Amigenics) (www.amigenics.com),
an innovative medical clinic specializing in prevention
and early detection of disease, announced their intent
to collaborate...
|
| |
. . . read the release |
| March
2, 2010 |
Biomoda Awarded Patent Securing Assay
Formulation and Use
Albuquerque,
NM (March 2, 2010) -Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com)
was today awarded U.S. patent 7,670,799, entitled,
"Composition and Method for Making 5, 10, 15, 20-
Tetrakis (Carboxyphenyl) Porphine (TCPP)"... |
| |
. . . read the release |
| February
10, 2010 |
Biomoda President Elected to NMBio Board
ALBUQUERQUE,
N.M.--(BUSINESS WIRE)--John Cousins, president of cancer
diagnostics company Biomoda, Inc. has been elected to
the Board of Directors of the New Mexico Biotechnology
and Biomedical Association (NMBio).
“I
know firsthand how receptive New Mexico is to the
bioscience industry...
|
| |
. . . read the release |
| February
2, 2010 |
Biomoda
President To Testify on Bill Funding Lung Cancer
Screening for Nebraska Veterans
Lincoln,
NE (Feb. 2, 2010) - Biomoda, Inc. (OTCBB: BMOD) President
John Cousins will testify before the Government,
Military and Veterans Affairs Committee of the Nebraska
Legislature on Wednesday, Feb. 3, 2010, in support of
legislation to provide funding to screen Nebraska
veterans... |
| |
. . . read the release |
| January
25, 2010 |
Biomoda Supports Nebraska Legislation
To Screen Veterans for Lung Cancer
Albuquerque,
NM (Jan. 25, 2010) – Cancer diagnostics company
Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com)
today applauded Nebraska State Sen. Bob Krist and his
co-sponsors for introducing legislation to screen up to
500 Nebraska veterans...
|
| |
. . . read the release |
| January
12, 2010 |
Biomoda Presents To Health Care Industry
in San Francisco
SAN FRANCISCO, CA, Jan.
12--Biomoda
President John Cousins recently presented an update on
the Biomoda diagnostic for early-stage lung cancer at
the OneMedPlace... |
| |
. . . read the release |
| January
11, 2010 |
Biomoda To Participate in OneMedPlace
Finance Forum
ALBUQUERQUE, N.M., Jan. 11--Cancer
diagnostics company Biomoda, Inc. (OTCBB: BMOD) will
present information on its proprietary CyPath®
diagnostic assay for the detection of early-stage lung
cancer at the OneMedPlace Finance Forum on Tuesday, Jan.
12, 2010, in San Francisco.
The OneMedPlace Finance Forum connects
emerging companies in the healthcare and life science
industries with investors and strategic partners that
can help bring new technologies...
|
| |
. . . read the release |
| December
10, 2009 |
Biomoda Partners with Christiana Care to
Complete Pilot Study on Cancer Diagnostic
ALBUQUERQUE, N.M., Dec.
10--Cancer diagnostics company Biomoda, Inc.
today announced that The Helen F. Graham Cancer Center
associated with Christiana Care Health System, a
screening site for the International Early Lung Cancer
Program (I-ELCAP), will recruit a cohort of patients
diagnosed with lung cancer to participate in the final
stage of the Phase II pilot study... |
| |
. . . read the release |
| December
2, 2009 |
Biomoda Urges N.M. Congressional
Delegation to Support Federal Legislation to Reduce Lung
Cancer Mortality
ALBUQUERQUE, N.M., Dec. 2--Cancer
diagnostics company Biomoda, Inc. today urged the
New Mexico congressional delegation to support the Lung
Cancer Mortality Reduction Act of 2009, which calls for
a comprehensive federal program to achieve a 50%
reduction...
|
| |
. . . read the release |
| November
11, 2009 |
Biomoda Commends N.M. Governor Bill
Richardson for Proclaiming National Lung Cancer
Awareness Month
ALBUQUERQUE, N.M., Nov.
3--Medical diagnostics company Biomoda, Inc.
today thanked New Mexico Governor Bill Richardson for
joining the fight against lung cancer by proclaiming
November as Lung Cancer Awareness Month... |
| |
. . . read the release |
| November
9, 2009 |
Biomoda Honors Veterans with Pledge to
Lower Rate of Lung Cancer
ALBUQUERQUE, N.M., Nov.
9--President John Cousins called upon governors in all
50 states to proclaim November “Lung Cancer Awareness
Month” on behalf of veterans and their families...
|
| |
. . . read the release |
| November
3, 2009 |
Biomoda Awarded New Patent
ALBUQUERQUE, N.M., Nov.
3--Biomoda, Inc., an Albuquerque-based cancer
diagnostics company, announces that it has received
notice of allowance for a U.S. Patent |
| |
. . . read the release |
| October
28, 2009 |
Biomoda Prepares for Phase III Clinical
Trials
ALBUQUERQUE, N.M., Oct. 28--Medical
diagnostics company Biomoda, Inc. is taking preliminary
steps to launch multisite Phase III clinical trials of
its in-vitro diagnostic for early-stage lung cancer...
|
| |
. . . read the release |
| October
27, 2009 |
Biomoda Board of Directors Names New
Corporate Secretary
ALBUQUERQUE, N.M., Oct. 27 -- The
Board of Directors of Biomoda, Inc. an early cancer
detection medical diagnostics company, has elected Maria
Zannes... |
| |
. . . read the release |
| October
23, 2009 |
Biomoda Enters Final Stage of Patient
Testing for Phase II Lung Cancer Clinical Study ALBUQUERQUE,
N.M., Oct. 23 -- Biomoda, Inc., a diagnostics company
focused on the development of accurate, inexpensive and
noninvasive in-vitro tests for the early detection of
cancer, has met its recruitment goal for New Mexico
veterans with a history of heavy smoking required to
complete the Phase II clinical trial...
|
| |
. . . read the release |
| September
30, 2009 |
Biomoda Engages Renowned Researcher to
Lead Longitudinal Component of Lung Cancer Study
ALBUQUERQUE, N.M., Sept. 30, 2009
(GLOBE NEWSWIRE) -- Biomoda, Inc. (OTCBB:BMOD
- News),
a diagnostics company focused on the development of
accurate, inexpensive, and noninvasive in-vitro tests
for the early detection of cancer, announced Dr. Thomas
Bauer will read the follow-up CT scans and other data on
study participants as part of the longitudinal component
of the research of the Phase II clinical trial of its
assay. Dr. Bauer is the Principal Investigator (PI)
overseeing the Phase II clinical trial... |
| |
. . . read the release |
| September
21, 2009 |
Biomoda Updates New Mexico Legislature
on Screening Program for New Mexico Veterans
ALBUQUERQUE,
N.M., Sept. 21, 2009 (GLOBE NEWSWIRE) -- In an update to
New Mexico state legislators, Biomoda, Inc. (OTCBB:BMOD
- News)
President John Cousins reported that the state-funded
lung cancer screening program for military veterans has
recruited 500 participants...
|
| |
. . . read the release |
| September
14, 2009 |
Biomoda Clinical Trial Adds
Longitudinal Study to Protocol
ALBUQUERQUE, N.M., Sept. 14, 2009 (GLOBE NEWSWIRE) --
Biomoda, Inc.'s (OTCBB:BMOD
- News)
(www.biomoda.com)
Phase II clinical trial to screen military veterans for
early-stage lung cancer has been enhanced to include a
longitudinal component, which will provide additional
data... |
| |
. . . read the release |
| August
4, 2009 |
Biomoda Study Will Screen 500 New
Mexico Veterans for Lung Cancer
SANTA
FE, N.M., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Biomoda, Inc.
(OTCBB:BMOD),
the New Mexico Department of Veterans Services, and the
New Mexico Institute of Mining and Technology (NM Tech)
appeared before the State Legislature's Interim Tobacco
Settlement Committee to report that 500 New Mexico
veterans have committed to participate in a state-funded
program for the detection of early-stage lung cancer...
|
| |
. . . read the release |
| August
3, 2009 |
Miss
New Mexico Helps Biomoda Recruit Veterans
Miner is devoting the year of her
reign to the fight against cancer, and she has agreed to
become an advocate and spokesperson for Biomoda’s
screening program for early-stage lung cancer.
Miner went to visit the American
Legion with Biomoda workers on Friday, July 31st to help
them recruit for Biomoda's... |
| |
. . . read the release |
| July
30, 2009 |
Biomoda
Adds to Patent Portfolio
ALBUQUERQUE,
N.M., Jul 27, 2009 (GlobeNewswire via COMTEX) - Biomoda, Inc. (OTC Bulletin
Board: BMOD)
Biomoda, Inc., an Albuquerque-based early cancer
detection medical diagnostics company, has filed a new
patent on a quantitative method for reading tissue
samples for signs of malignant tumor cells, bringing the
company's U.S. patent portfolio to four total patents
issued or pending.
Biomoda's
diagnostic for the early detection of various...
|
| |
. . . read the release |
| July
30, 2009 |
Biomoda President Testifies Before New
Mexico Legislature Supporting Clinical Funding for
an Early Lung Cancer Detection Study
Santa
Fe, N.M., July 28, 2009 -- John Cousins, President of
Biomoda, Inc. (OTC Bulletin Board: BMOD),
Albuquerque, New Mexico, (http://www.biomoda.com)
, testifies Wednesday, July 29th before the New Mexico
State Legislature’s Interim Tobacco Settlement
Committee to report the progress screening veterans... |
| |
. . . read the release |
| June
16, 2009 |
Biomoda
Recognized as One of Top NM Technology Companies
Albuquerque,
NM (July 10, 2009) – Biomoda, Inc. (OTC Bulletin
Board: BMOD) has been named one of the 2009 New Mexico
Technology Flying 40, an annual award given to the 40
fastest-growing technology companies headquartered in
New Mexico.
Biomoda is a medical diagnostic company
focused on the early...
|
| |
. . . read the release |
| June 15, 2009 |
New Mexico Tech to Present Biomoda Data at International Lung Cancer Conference
Albuquerque, NM (June 15, 2009) – The New Mexico Institute of Mining and Technology (NM Tech) will present data from Biomoda,Inc. (OTCBB : BMOD) on its non-invasive, inexpensive and accurate diagnostic test for the early detection of lung cancer at the 13th World Conference on Lung Cancer in San Francisco, CA, July 31 to August 4, 2009.
|
| |
. . . read the release |
| June 09, 2009 |
Over 400 Vets Enroll in Biomoda Lung Cancer Screening Program
Albuquerque, NM (June 9, 2009) – More than 400 New Mexico veterans have volunteered to participate in a screening program for the early detection of lung cancer based on a non-invasive diagnostic tool developed by Biomoda, Inc. (OTC Bulletin Board:BMOD) and trademarked under the name CyPath™.
|
| |
. . . read the release |
| March 5, 2009 |
Biomoda Approved To Begin Screening Veterans for Lung Cancer
Albuquerque, NM (March 5, 2009) – Biomoda, Inc. (OTC Bulletin Board: BMOD), a medical diagnostics company based in Albuquerque, received approval from an independent Institutional Review Board (IRB) to begin Phase I clinical trials of its cytology-based screening technology for early detection of cancer.
|
| |
. . . read the release |
| Jan. 8, 2009 |
Biomoda, Inc. - WESST Enterprise Center’s First Incubator Member
Albuquerque, NM: Jan. 8, 2009 – Pioneering new medical technical processes in cancer detection, Biomoda, Inc. has joined the WESST Enterprise Center’s (WEC) business incubation program. Biomoda is focusing on validation of its primary product CyPath®, a noninvasive and accurate test for early detection of lung, cervical and bladder cancer.
|
| |
. . . read the release |
|
|
|
|
|
|
